ArticleCell death & disease2021

Gemcitabine and APG-1252, a novel small molecule inhibitor of BCL-2/BCL-XL, display a synergistic antitumor effect in nasopharyngeal carcinoma through the JAK-2/STAT3/MCL-1 signaling pathway.

Fan Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.